Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
<20 |
20-39 |
>39 |
Base (known status) |
|---|---|---|---|---|
Czech Republic |
1.7 |
2.6 |
3.1 |
2114 |
Denmark |
2.3 |
3.4 |
3.3 |
3911 |
Germany |
3.5 |
4.3 |
2.6 |
44215 |
Greece |
2.6 |
6.5 |
9.6 |
2371 |
Italy |
3.7 |
6.9 |
6.6 |
162230 |
Cyprus |
2.7 |
7.4 |
|
237 |
Luxembourg |
0.8 |
2.1 |
6.8 |
232 |
Hungary |
2.8 |
3.8 |
0.9 |
9145 |
Malta |
3.8 |
6.6 |
28.0 |
660 |
Netherlands |
3.5 |
4.8 |
4.0 |
9887 |
Slovakia |
3.8 |
4.9 |
0.7 |
735 |
Slovenia |
2.1 |
4.0 |
4.3 |
1113 |
Finland |
1.7 |
2.5 |
3.6 |
1808 |
Sweden |
1.9 |
2.5 |
1.4 |
2163 |
United Kingdom |
2.0 |
2.6 |
2.8 |
90276 |
Bulgaria |
1.7 |
4.1 |
3.9 |
1433 |
|
|
|
|
|
Total |
2.7 |
4.4 |
4.4 |
332530 |
Notes: The table is left blank where there are no female cases. See also 'General notes for interpreting data' on the Explanatory notes and help page. Source: 2005 Reitox national reports - TDI outpatient treatment centres | ||||